logo-loader
Novaliq

Novaliq making headway with its water-free eye drops

Novaliq CEO Christian Roesky sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The Heidelberg, Germany based pharmaceutical company is focusing on the development and commercialization of ocular therapeutics based on EyeSol, a water-free technology for ophthalmology products.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics begins trading on the OTCQB under the ticker...

Empower Clinics (CSE: CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley sat down with Steve Darling from Proactive Vancouver to share news the company is now trading in the United States. Empower is now listed on the OTCQB market and McAuley talks about what this means for the company and...

51 minutes ago

2 min read